Grace Hampson : Citation Profile


Are you Grace Hampson?

Office of Health Economics

1

H index

0

i10 index

6

Citations

RESEARCH PRODUCTION:

4

Articles

15

Papers

RESEARCH ACTIVITY:

   4 years (2015 - 2019). See details.
   Cites by year: 1
   Journals where Grace Hampson has often published
   Relations with other researchers
   Recent citing documents: 5.    Total self citations: 3 (33.33 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pha1219
   Updated: 2019-11-16    RAS profile: 2019-04-29    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers


Works with:

Towse, Adrian (9)

Devlin, Nancy (6)

Cole, Amanda (3)

Berdud, Mikel (2)

Garau, Martina (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Grace Hampson.

Is cited by:

Lorgelly, Paula (1)

Cites to:

Towse, Adrian (8)

Lancsar, Emily (3)

Baltagi, Badi (3)

Moscone, Francesco (3)

Devlin, Nancy (3)

Cole, Amanda (2)

Shah, Koonal (2)

Tsuchiya, Aki (2)

He, Xuezhong (2)

Soares, Marta (2)

Claxton, Karl (2)

Main data


Where Grace Hampson has published?


Working Papers Series with more than one paper published# docs
Research Papers / Office of Health Economics7
Consulting Reports / Office of Health Economics4
Briefings / Office of Health Economics4

Recent works citing Grace Hampson (2019 and 2018)


YearTitle of citing document
2018Funding breakthrough therapies: A systematic review and recommendation. (2018). Hanna, E ; Auquier, P ; Badora, K ; Dabbous, O ; Borissov, B ; Dussart, C ; Toumi, M. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:3:p:217-229.

Full description at Econpapers || Download paper

2019Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance. (2019). Crispi, Francisca ; Mossialos, Elias ; Osipenko, Leeza ; Barkauskaite, Eva ; Naci, Huseyin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:17:y:2019:i:2:d:10.1007_s40258-018-0438-y.

Full description at Econpapers || Download paper

2018The Future of Precision Medicine: Potential Impacts for Health Technology Assessment. (2018). Love-Koh, James ; Taylor, Matthew ; Wood, Hannah ; Chalkidou, Anastasia ; Manca, Andrea ; Lovett, Rosemary ; Ennis, Kate ; Rejon-Parrilla, Juan Carlos ; Peel, Alison. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0686-6.

Full description at Econpapers || Download paper

2018Multi-Indication Pricing: Nice in Theory but Can it Work in Practice?. (2018). Mestre-Ferrandiz, Jorge ; Hidalgo-Vega, alvaro ; Alcala, Bleric ; Zozaya, Neboa . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0716-4.

Full description at Econpapers || Download paper

2018The Impact of Brexit on Pharmaceuticals and HTA. (2018). Lorgelly, Paula. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-018-0072-5.

Full description at Econpapers || Download paper

Works by Grace Hampson:


YearTitleTypeCited
2016New Age Decision Making in HTA: Is It Applicable in Asia? In: Briefings.
[Full Text][Citation analysis]
paper0
2017Assessing Value, Budget Impact and Affordability to Inform Discussions on Access and Reimbursement: Principles and Practice, with Special Reference to High Cost Technologies In: Briefings.
[Full Text][Citation analysis]
paper0
2017How can HTA meet the needs of health system and government decision makers? In: Briefings.
[Full Text][Citation analysis]
paper0
2017Transferability of HTA In: Briefings.
[Full Text][Citation analysis]
paper0
2016Four Case Studies to Explore the Added Value of Oxford AHSN In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2017Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose? In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2017Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market In: Consulting Reports.
[Full Text][Citation analysis]
paper1
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]
paper0
2015Dementia: The R&D Landscape In: Research Papers.
[Full Text][Citation analysis]
paper0
2016A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications In: Research Papers.
[Full Text][Citation analysis]
paper1
2016Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: Research Papers.
[Full Text][Citation analysis]
paper0
2018Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).(2018) In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0
article
2017Gene Therapy: Understanding the Science, Assessing the Evidence, and Paying for Value In: Research Papers.
[Full Text][Citation analysis]
paper1
2017Macro Evaluation of the NIHR Oxford Biomedical Research Centre In: Research Papers.
[Full Text][Citation analysis]
paper0
2018Real World Evidence for Coverage Decisions: Opportunities and Challenges In: Research Papers.
[Full Text][Citation analysis]
paper1
2018Understanding the Context, Selecting the Standards: A Framework to Guide the Optimal Development and Use of Real-World Evidence for Coverage and Formulary Decisions In: Research Papers.
[Full Text][Citation analysis]
paper0
2017What Determines the Health Care Expenditure of High Income Countries? A Dynamic Estimation In: Applied Economics and Finance.
[Full Text][Citation analysis]
article0
2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]
article2
2019Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare In: The European Journal of Health Economics.
[Full Text][Citation analysis]
article0

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated November, 11 2019. Contact: CitEc Team